|1.||Beijnen, Jos H: 6 articles (10/2013 - 01/2006)|
|2.||Schinkel, Alfred H: 4 articles (04/2010 - 03/2005)|
|3.||van Tellingen, Olaf: 3 articles (10/2013 - 12/2007)|
|4.||Schellens, Jan H M: 3 articles (10/2013 - 01/2006)|
|5.||Mazzanti, Roberto: 3 articles (10/2013 - 12/2007)|
|6.||Marchetti, Serena: 3 articles (10/2013 - 12/2007)|
|7.||Miura, Masatomo: 3 articles (11/2010 - 10/2008)|
|8.||Machida, Ikuo: 3 articles (04/2005 - 01/2003)|
|9.||Wakusawa, Shinya: 3 articles (04/2005 - 01/2003)|
|10.||Hayashi, Hisao: 3 articles (04/2005 - 01/2003)|
|1.||Breast Neoplasms (Breast Cancer)
09/01/2011 - "Breast cancer resistance protein (BCRP) and multidrug resistance protein 2 (MRP2) can play a role in the absorption, distribution, metabolism, and excretion of drugs, impacting on the potential for drug-drug interactions. "
09/01/2011 - "Validation of membrane vesicle-based breast cancer resistance protein and multidrug resistance protein 2 assays to assess drug transport and the potential for drug-drug interaction to support regulatory submissions."
03/01/2005 - "From this standpoint, we performed in situ intestinal perfusion experiments by using Eisai hyperbilirubinemic rats (EHBRs) in which the multidrug resistance protein 2 (Mrp2/Abcc2) is hereditarily defective and breast cancer resistance protein (Bcrp1/Abcg2) knockout mice. "
12/01/2012 - "Immunohistochemical characterization showed the formation of neo-tissue with expression of CYP2C9 and CYP3A4 and the drug transporters breast cancer resistance protein (BCRP) and multidrug resistance protein 2 (MRP2) in the bioreactor. "
12/30/2015 - "The transport and cellular accumulation studies in Madin-Darby canine kidney (MDCK) cells overexpressing human multidrug resistance protein 2 (MRP2) or P-gp and LLC-PK1 cells overexpressing human breast cancer resistance protein (BCRP) were performed. "
|2.||Chronic Idiopathic Jaundice (Dubin Johnson Syndrome)
04/01/2005 - "Recent studies have indicated that dysfunction or loss of the multidrug resistance protein 2 (MRP2) is the molecular basis of Dubin-Johnson syndrome (DJS). "
05/01/2013 - "Mutation and functional analysis of ABCC2/multidrug resistance protein 2 in a Japanese patient with Dubin-Johnson syndrome."
02/01/2005 - "A novel ancestral splicing mutation in the multidrug resistance protein 2 gene causes Dubin-Johnson syndrome in Ashkenazi Jewish patients."
10/05/2001 - "Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome."
12/01/2000 - "Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome."
01/01/2013 - "P-glycoprotein 1 (Pgp1) is a transmembrane efflux pump well characterised in drug resistant cancer cells. "
02/15/2011 - "Although multidrug resistance protein 2 (MRP2) confers chemoresistance in some cancer types, its implication on oesophageal squamous cell carcinoma (ESCC) remains unclear. "
09/01/2005 - "Impaired expression of hepatic multidrug resistance protein 2 is associated with posthepatectomy hyperbilirubinemia in patients with biliary cancer."
04/01/2008 - "The expression of P-glycoprotein (P-gp), multidrug resistance protein 1 (MRP1) and multidrug resistance protein 2 (MRP2) in liver (HepG2), colon (Caco-2) and lung (A549) cancer cells treated with ER or SF was analyzed by Western blotting. "
12/01/2009 - "Increased expression of several ABC-transporters, especially P-glycoprotein (P-gp) and multidrug resistance protein 2 (MRP2), are observed in multidrug resistant (MDR) tumor cells and on HIV-1 infected lymphocytes. "
|4.||Renal Insufficiency (Renal Failure)
|5.||Status Epilepticus (Complex Partial Status Epilepticus)
06/01/2012 - "The aim of this study was to investigate whether NMDA receptor was involved in the upregulation of multidrug resistance protein 2 (Mrp2) expression during status epilepticus (SE). "
06/01/2012 - "MK-801 prevents overexpression of multidrug resistance protein 2 after status epilepticus."
|3.||Adenosine Triphosphate (ATP)
|4.||Reduced Folate Carrier Protein
|5.||Amino Acid Transport Systems (Amino Acid Transporter)
|1.||Drug Therapy (Chemotherapy)